Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 1.7B | 3.1B | 2.6B |
Cost of revenue | 1.8B | 1.3B | 2.4B | 2.0B |
Gross profit | 346.6M | 415.4M | 725.4M | 579.5M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 208.3M | 199.7M | 244.4M | 198.7M |
Operating income | -7.4M | 48.4M | 298.9M | 225.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 39.7M | 32.6M | 29.9M | 26.8M |
Other income expense | — | — | — | — |
Pretax income | -31.9M | 15.4M | 272.0M | 202.1M |
Tax provision | -7.4M | 3.6M | 61.8M | 51.4M |
Net income | -24.5M | 11.8M | 210.3M | 150.7M |
Basic EPS | — | 0.4 | 6.2 | 4.5 |
Diluted EPS | — | 0.4 | 6.2 | 4.5 |
Basic average shares | — | 33.7M | 33.8M | 33.8M |
Diluted average shares | — | 33.7M | 33.8M | 33.8M |
EBITDA | 53.5M | 94.6M | 347.8M | 273.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |